Clinical Trial

Cell-based Non-invasive Prenatal Test Workflow

Study acronym: TOTAL#5
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to optimize a new non-invasive prenatal screening method based on the capture of fetal cells from maternal blood and to complete its development by obtaining maternal blood samples during the first trimester of pregnancy.
Trial Details
NCT Number NCT07566780
Lead Sponsor Menarini Silicon Biosystems
Conditions Pregnant Women
Enrollment 1,400 participants
Start Date 2026-05-04
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05